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RESUMEN
Un total de 240 pollos broiler Hybro de 1 día de edad se dividieron en cuatro grupos. Estos grupos fueron alimentados con una dieta completa 
basada en maíz/soya, con y sin la adición de antibiótico promotor del crecimiento (AGP, Flavomycin®, 15 PPM, Intervet), alimento microbiano dirigido 
(DFM, All-Lac® 0,1%, Alltech Inc. USA) y Manano Oligosacárido (MOS) (Bio-MOS® 2 kg/T, Alltech Inc. USA). Los pollos fueron introducidos en el 
experimento después de nacer. En el día 42 de ensayo todas las aves fueron sacrificadas en una planta de faenamiento y sus rendimientos al sacrificio 
fueron medidos. Muestras de intestinos con su contenido de 6 aves promedio, seleccionadas al azar de cada grupo (n = 24), fueron tomadas para su 
examen. Al final del ensayo, el peso corporal (BW) y la ganancia diaria promedio (ADG) de los pollos alimentados con las raciones que contenían 
Bio-MOS® (1915,23 y 44,58 g), AGP (1869,40 y 43,50 g) y DFM (1855,50 y 43,17 g) fueron significativamente mayores que las de los pollos del 
grupo control (1815,67 y 41,96 g). Comparado con el grupo control (91,19 g), el consumo promedio diario de alimento (ADFI) también fue reducido 
significativamente en los grupos experimentales suplementados con Bio-MOS® (81,84 g), DFM (83,50 g) o AGP (86,16 que g), lo cual disminuyó la 
relación de conversión (FCR) de 2,17 en el grupo control a 1,83, 1,93 y 1,98 kg, respectivamente. Una disminución significativa del pH del contenido 
intestinal en diversas partes del tracto gastrointestinal fue observada en los grupos de pollos suplementados con Bio-MOS (6,25, 6,50 y 6,78) y DFM (6,16, 6,46 
y 6,72), comparado con los grupos control (6,55, 6,81 y 7,21) y adicionado de AGP (6,61, 6,87 y 7,14). El uso de DFM y de Bio-MOS® aumentó la longitud 
y el ancho de las vellosidades intestinales y disminuyó la profundidad de criptas. El número de células caliciformes no se diferenció estadísticamente 
entre grupos experimentales. En conclusión, los grupos suplementados con Bio-MOS® y DFM presentaron ventajas nutricionales, farmacológicas y 
económicas con respecto al grupo que incorporó un promotor de crecimiento antibiótico.
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INTRODUCTION
The practice of feeding livestock with subtherapeutic 
levels of antibiotics has been in use for over fifty years. 
Antibiotics affect microflora by altering the metabolism of 
microorganisms, and suppresing microbial growth in the gut 
(Gadd 1997). Usage of antibiotics has negative effects on 
animal’s health and production such as residua in tissues, 
long withdrawal period, and development of resistance in 
microorganisms, allergies and genotoxicity (Markovicv 2005). 
In this trial 8% Flavomycin®, an antibiotic produced from 
culture of Streptomyces bambergiensis, was used.
Over the past few years, a great deal of interest has 
been generated on the evaluation of alternative means for 
manipulation of gastrointestinal microflora in livestock. The 
motivation for examining these alternatives comes from 
increased public scrutiny about the use of antibiotics in 
the animal feed industry as well as the need for a safe food 
supply. According to European legislation, all antibiotic 
growth promoters (AGP) are forbidden in feed. During 
the past few years numerous trials have been conducted 
to compare the incorporation of mannan-oligosaccharides 
(MOS) and direct feed microbials (DFM) in the diets, versus 
conventional AGP. Supplementation of poultry diets with 
commercially available MOS and DFM enhances profitability 
by improving performance parameters in live birds (Iji and 
Tivey 1998). Probiotics are additives composed of living 
microorganisms which induce beneficial effects in animal 
organism by eubiosis without antibiotic addition into the feed, 
as defined by Parker (1974), Fuller (1977) and Vanbelle et al 
(1990). Recently, DFM, a source of live microorganisms like 
bacteria, fungi and/or yeasts have been introduced (Miles 
and Bootwalla 1991). There are numerous mechanisms by 
which intestinal microflora inhibits gut colonisation with 
invasive microorganisms, as described by Rolfe (1991). 
These mechanisms include aggregation of lactic bacteria to 
pathogenic bacteria, competition at adherence site, nutritive 
competition between microorganisms and bactericide effects. 
The additives such as DFM contain some beneficial bacteria 
that coat the intestinal villa and prevent Coliform bacteria and 
other bacteria from attaching to the intestinal wall (Spring 
1996). The active principles of All-LAC® are Lactobacillus 
acidophillus and Streptococcus faecium (minimum bacterial 
count 1,5 x 109 CFU/colony forming units).
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Prebiotics have been defined as non digestible feed 
ingredients, which are growth substrates, specifically 
directed towards potentially beneficial bacteria already 
existing in caecum and colon. Several studies have shown 
that addition of prebiotics to the diet of broiler, layer and 
pig leads to improved performance through improving gut 
microflora (Xu et al 2003, Spring et al 2000, Pelicano et al 
2004). In contrast to the antibiotic mode of action, which 
limits or suppresses growth of common Gram-positive 
microflora, mannan-oligosaccharides (Bio-MOS®) and 
other oligosaccharides can prevent attachment of Gram-
negative pathogens to enterocytes. Bio-MOS® derived 
from Saccharomyces cerevisiae cell wall, is commonly 
available as a feed supplement, and is included in diets 
as a generally recognised safe compound. The benefits of 
MOS are based on different specific properties including 
reduction of the intestinal mucous cells turnover rate (Iji 
and Tivey 1998). These properties have the potential to 
enhance growth rate and feed conversion in commercial 
broilers diet. Bacterial pathogens, which bind to the intes-
tinal wall via mannose bearing lectins, bind to the dietary 
MOS instead and are eliminated harmlessly (Sharon and 
Lis 1993). The removal of AGPs has led to the search of 
alternative growth promoters. The alternative products must 
be safe for animals, consumers and the environment.
The objective of this trial was to investigate the effect 
of dietary supplementation with Bio-MOS® (Alltech Inc, 
USA), direct-fed microbials (All-Lac®, Alltech Inc, USA) and 
antibiotic growth promoters (AGP, Flavomycin®, Intervet) 
on the performances and gut morphology of broilers. The 
gastrointestinal tract is a front - defense line against the 
constant invasion of microbes. The gastrointestinal fauna of 
the bird is an important factor in poultry performance and 
flock health.
MATERIAL AND METHODS
The completely randomised experimental design 
included 240 one-day-old male broiler chicks (sexed, 
Hybro) from a commercial hatchery. Animals were fed 
commercial complete corn-soybean based diets (table 1). 
Diet 1 was used from 1st to 20th day, diet 2 from 21st to 34th 
day and finally diet 3 was used from 35th until 42nd day. 
Four treatment groups of 60 chickens each, were fed the 
diet with supplementation of AGP (15 ppm Flavomycin®, 
AGP group), DFM (All-LAC® 1kg/T, DFM group), 2 kg/T 
Bio-MOS® (MOS group) and withouth additives (control 
group). All birds had ad libitum access to feed.
The following parameters were evaluated during the 
experimental period: body weight (on day 42), average body 
weight gain, feed intake and feed gain ratio. Feed intake 
was measured on a daily basis, as the difference between 
the feed mass given to the animals and the feed mass left in 
the rack. At day 42 of trial, all broilers were conventionaly 
sacrificed by cervical dislocation technique, as described in 
the Report of the AVMA Panel on Euthanasia (AVMA 2001). 
Table 1. Composition of experimental diets at days 1- 42 of age.
 Composición de dietas experimentales entre 1- 42 días de edad.
Diet
1
(1.-20. días)
2
(21.-34. días)
3
(35.-42. día)
Ingredient
Maize 56.73 63.30 67.75
Soybean meal 26.30 15.30 17.00
Fishmeal 4.00 4.00 –
Sunflower meal – 5.00 6.00
Gluten meal, corn 6.00 6.00 4.00
Oil 3.00 3.00 2.00
Limestone 1.10 0.70 1.00
Dicalcium phosphate 1.30 1.30 1.00
Salt 0.20 0.25 0.25
Methionine 0.12 – –
Lysine 0.25 0.15 –
Vitamin-mineral 
premix* 1.00 1.00 1.00
Calculated composition %
Protein 21.80 19.40 17.30
Ca 1.07 0.89 0.75
P 0.74 0.75 0.61
ME, MJ/kg 12.96 13.27 13.15
Lysine 1.38 1.05 0.76
Methionine + 
cystine 0.78 0.63 0.55
* including Flavomycin®, DFM or Bio-MOS®.
Samples of small intestine (second third), which correspond 
to the surpass of duodenum to jejunum, and jejunum to 
ileum, were taken for examination from 6 average broilers 
(randomly selected) from each group (n = 24) Sections of 
5-8 mm thickness were taken from each sample and fixed 
in 10% formalin solution and absolute alcohol and embed-
ded in paraffin. Sections were cut, mounted on slides and 
stained with the HE method as described by Scheuer and 
Chalk (1986). Morphometric examinations (villus height and 
width, as well as crypt depth) were done by light microscopy 
using an ocular micrometer 1:100 as described by Djolai 
et al (1998), while stereologic determination of goblet cells 
number was carried out using a multipurpose test system 
M42 as described by Wiebel (1979). At the end of the trial, 
the pH of intestinal content in different gastrointestinal parts 
(duodenum, ileum, caecum) was measured.
STATISTICAL ANALYSIS
The values obtained were expressed as mean ± SD. 
In order to analise the relation between intergroup mean 
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differences, ANOVA, Tukey and student’s t-tests were 
performed at significance levels of 1% and 5% (Snedecor 
and Cochran 1971). Software package PrismaPad v.4.0 
was used for statistical calculation.
RESULTS AND DISCUSSION
Body weight, average growth, daily feed intake and 
feed gain ratio during the entire trial period are presented 
in table 2.
After 42 days, it was observed that the BW of the animals 
fed with Bio-MOS® diet differed significantly compared 
to the other groups (P <	0.05). This led to significantly 
higher body weight gain in the experimental rather than 
in the control group during the total period (P <	0.05). 
Feed conversion was also reduced significantly when Bio-
MOS®, DFM or AGP were administered to the feed and 
this was observed during the entire trial period (table 2, 
P <	0.05). As a result, feed to gain ratio was significantly 
reduced in trial groups compared to the control and the 
AGP fed birds (P <	0.05).
The data presented in the table 3 shows that electro-
chemical reaction increases along the digestive tract of 
broilers, with the highest values being registered in the 
terminal parts of the intestines in all groups included in 
the trial. The differences of pH values between control 
and AGP group among corresponding segments of the 
intestines were non-significant, while the decrease of 
the pH in the duodenal content ranged from significant 
(P	<	0.05) to very significant (P <	0.01) in the other two 
groups.
The supplementation with Bio-MOS® and DFM led 
to an increase in villus height and width, as well as a de-
crease in crypt depth in all parts of the intestine (P < 0.05), 
(table 4, figures 1-3).
Supplementation of animal diets with various addi-
tives aims to increase production and quality of food 
of animal origin. The results obtained in the present 
study are similar to those described by Roch (1998) 
and Waldroup et al (1970) obtained in nutrition ex-
periments with antibiotic and Bio-MOS®. Probiotics 
induce similar and even better effects compared to 
Table 2. Average body weight (BW), average body broiler weight gain (BWG), average daily feed intake (ADFI) and average feed 
conversion ratio (FCR) during the entire trial period for the broiler treatment groups.
 Promedios de peso corporal (BW), de aumento del peso corporal (BWG), del consumo diario de alimento (ADFI) y del cociente de con-
versión de la alimentación (FCR) durante el período de prueba completo para los grupos de broiler en tratamiento.
Parameters
Group
Control AGP* DFM** MOS***
BW (kg) 1815.67a 1869.40b 1855.50c 1915.23a, b, c
BWG (g/d) 41.96a, b, c 43.50a 43.17b 44.58c
ADFI (g/d) 91.19 86.16 83.50 81.84
FCR (kg) 2.17 1.98 1.93 1.84
Values expressed as x–; a, b, c P < 0.05
* AGP - Antibiotic Growth Promoters
** DFM - Direct Feed Microbials
*** MOS - Manan Oligo Saccharids
Table 3. Mean and standard deviation for pH value of chime in the intestine of broilers on day 42.
 Media y desviación estándar para el valor de pH del quimo en el intestino de los broilers en el día 42.
Segment
Group
Control AGP* DFM** MOS***
Duodenum 6.55 ± 0.25a, A 6.61 ± 0.26b, B 6.16 ± 0.15A, B 6.25 ± 0.21a, b,
Ileum 6.81 ± 0.20a, b 6.87 ± 0.33c, d 6.46 ± 0.21c 6.50 ± 0.26b, d
Caecum 7.21 ± 0.33a, b, A 7.14 ± 0.24c, d 6.72 ± 0.26b, c, A 6.78 ± 0.29a, d
Values expressed as x–; SD; a, b, c, dP < 0.05; A,BP < 0.01
* AGP - Antibiotic Growth Promoters
** DFM - Direct Feed Microbials
*** MOS - Manan Oligo Saccharids
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Table 4. Effect of treatments on broiler gut morphology [µm] on day 42.
 Efecto de los tratamientos en la morfología del intestino de los broilers [µm] en el día 42.
Group
Control AGP* DFM** MOS***
Duodenum
Villus height 901.28 ± 70.02a, b 981.07 ± 77.01c, d 1008.35 ± 40.64a, c 1013.08 ± 81.98b, d
Villus width 93.72 ± 15.11a, b, c 98.58 ± 8.10a 104.48 ± 17.40b 107.70 ± 13.91c
Crypt depth 140.35 ± 27.20a, b 137.52 ± 18.23c, d 126.18 ± 30.06a, c 123.72 ± 32.10b, d
Ileum
Villus height 452.77 ± 181.13a, b, A 478.32 ± 124.35c, d, B 541.27 ± 100.82a, c 640.53±115.95 b, d, A, B
Villus width 87.15 ± 10.92a 90.28 ± 18.83b 90.05 ± 13.53c 95.12 ± 12.30a, b, c
Crypt depth 111.93 ± 14.06a, b 103.98 ± 34.03c, d 84.20 ± 24.90a, c 86.52 ± 10.90b, d
Caecum
Villus height 160.22 ± 29.77a, b 163.08 ± 48.67c 166.48 ± 46.19a 171.25 ± 44.06b, c
Villus width 59.08 ± 6.55a, b, c 66.77 ± 12.34a 65.27 ± 10.49b 65.10 ± 16.29c
Crypt depth 42.23 ± 11.77a, b 40.83 ± 8.67c, d 31.37 ± 8.53a. c 31.75 ± 7.82b. d
Values expressed as x–; SD; a, b, c, dP < 0.05 A, P < 0.01
* AGP - Antibiotic Growth Promoters.
** DFM - Direct Feed Microbials.
*** MOS - Manan Oligo Saccharids.
a. Control b. AGP c. DFM d. MOS
Figure 1. Histological figure of broiler duodenum (obj. 1:100, HE) for different treatment groups.
 Figura histológica de duodeno de broiler (obj. 1:100, HE) para los diversos grupos en tratamiento.
Flavomycin® as defined by Owings et al (1990). The 
increased weight gain is achieved by prebiotics and the 
increased range from 2-6%, as reported by Kumprecht 
et al (1998), Roch (1998), Petersen (1998), Newman 
Melissa (1990) and Pupavac et al (1998). This was also 
confirmed in our trial for prebiotic supplementation 
(MOS group).
Adding MOS in broiler feed significantly increased 
villous length but not villous width as reported by Spring 
(1996). Besides Bradly et al (1994) noticed simultaneous 
decrease of crypt depth, which is in agreement with reports 
by Savage et al (1997).
There is substantial evidence that dietary MOS modifies 
the morphology and structure of the intestinal mucous as 
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a. Control b. AGP c. DFM d. MOS
Figure 2. Histological figure of broiler ileum, (obj. 1:100, HE) for different treatment groups.
 Figura histológica de ileon de broiler, (obj. 1:100, HE) para los diversos grupos en tratamiento.
a. Control b. AGP c. DFM d. MOS
Figure 3. Histological figure of broiler caecum, (obj. 1:100, HE) for different treatment groups.
 Figura histológica de intestino ciego de broiler, (obj. 1:100, HE) para los diversos grupos en tratamiento.
defined by Shane (2001). Enterocytes undergo a continual 
cycle of proliferation in the intestinal crypt, cell maturation 
and migration up the villa with desquamation at the tip 
of the villa. The depth of the crypts is correlated to cell 
replacement rate (Savage et al 1997). Accelerated replace-
ment of enterocytes requires energy and proteins, which 
can deprive growth and the development of other tissues 
and organ systems. Thus, the decreased crypt height will 
be correlated to a significant increase in growth rate as 
occurred in the present study.
Adding DFM to broiler feed provides more stable resi-
dent microflora, which consequently provides better 
conditions for longer enterocyte life. Longer villa increases 
the absorptive surface of intestines, while smaller crypts 
indicate lower tissue turnover as well as lower demand 
for tissue development.
The evaluations performed have confirmed that 
antibiotics applied as growth promoters gave positive 
effects on average weight gain (5% higher, on average) 
and on feed to gain ratio (approximate decrease of 6%) in 
growing animals as reported by Gadd (1997). It has also 
been confirmed that feed supplements with probiotic and 
prebiotic effects both act as efficient growth promoters in 
domestic fowl, i.e. increasing daily gain for 8-10% with 
decreased feed gain ratio for 10-15%, as described by 
Petersen (1998) and Owings et al (1990). On the basis 
of data obtained it was concluded that alternative growth 
promoters enhance growth by stimulation of physiological 
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potentials and mechanisms in animals together with avoid-
ing antibiotics in feeds as described by Ferket et al (2002) 
and Newman (2002). Probiotic and prebiotic supplements 
accomplish similar effects on animals as antibiotics, while 
undesired effects like tissue residua, withdrawal period, 
development of resistance in microorganisms, allergies, 
genotoxic effects, etc. are avoided as reported by Veld 
(1997) and Hooge (2003).
Antibiotics induce enlargement of villous length and 
width along with a decrease of depth of intestinal crypts, 
which can be correlated with a decrease of total microbial 
population and a shift to more beneficial composition of 
intestinal microflora.
These effects, especially the observed increase in duo-
denal villous length and decreased depth of the crypts are 
potentiated when probiotics are used. Dunham et al (1993) 
presented similar conclusions in domestic fowl fed a diet 
supplemented with L. Reuteri which had longer villa and 
lower crypts in ileum compared to the controls.
The most evident positive effects on digestion were 
achieved in intestines of broilers fed with feed supplemented 
with MOS. Olygosacharides can act negatively on digestion 
of energetic components as described by Coon et al (1990) 
and Leske et al (1993), as well as on the fact that volatile 
fatty acids stimulate peristalsis, therefore diminishing the 
period of food passage and possible time of absorption 
as reported by Hellendroon (1979). On the other hand, a 
compensatory mechanism reflected on the increase of villa 
length in the ileum has been reported by Choi et al (1994). 
Spring (1996) confirmed that mannan-olygocacharides in 
feed have a significant effect (P < 0.05) on the length of 
the intestinal villa. They did not observe any significant 
difference in the width of the villa. The results obtained 
by Bradley et al (1994) and Shane (2001), who revealed 
that along with the increase of the length of intestinal 
villa a decrease of the crypt depth is observed, agree with 
this finding. The results of Savage et al (1997) have also 
confirmed that the depth of the crypts is decreased in the 
intestine of the broilers treated with MOS.
The described changes in intestinal morphology can 
explain the observed beneficial effects on productivity, as 
reported by Loodi et al (2004). The enlargement of the length 
and width of the intestinal villa increases the absorptive 
surface that is prominent when alternative growth stimula-
tors are applied. At the same time the observed decrease of 
the depth of the crypts can indicate a decrease of enterocyte 
replacement and a decrease in cellular turnover.
It can be concluded that the use of probiotics and pre-
biotics as alternative growth promoters and controllers of 
growth entheropathogenic bacteria has nutritive, medical 
and economic advantages.
SUMMARY
A total of 240 Hybro broilers was divided into 4 groups. These groups 
were fed a complete corn/soybean based diet with and without addition 
of antibiotic growth promoters (AGP, Flavomycin® 15 ppm, Intervet), 
direct feed microbials (DFM, All-Lac® 1kg/T, Alltech Inc. USA) and 
mannanoligosaccharide (MOS) (Bio-MOS® 2kg/T, Alltech Inc. USA). 
Chickens were introduced into the experiment after hatching. At day 42 
of trial, all broilers were conventionaly sacrificed in a slaughter plant 
and slaughter performances were measured. Samples of intestines with 
its content from 6 average broilers (randomly selected) from each group 
(n=24) were taken for examination. At the end of the trial, body weight 
(BW) and body weight gain (BWG) of broilers fed the diet containing 
Bio-MOS® (1915.23 and 44.58 g), AGP (1869.40 and 43.50 g) and 
DFM (1855.50 and 43.17g) were significantly higher than in birds of the 
control group (1815.67 and 41.96 g). When compared with the control 
group (91.19 g), ADFI (average daily feed intake) was also significantly 
reduced when Bio-MOS® (81.84 g), DFM (83.50g) or AGP (86.16 g) 
were supplemented which lead to a lower feed conversion ratio (FCR), 
2.17 vs. 1.83, 1.93 and 1.98 kg, respectively. A significantly lower pH 
of the intestinal content of intestines (duodenum, ileum, caecum) was 
observed in groups fed DFM (6.16, 6.46 and 6.72) and Bio-MOS® 
(6.25, 6.50 and 6.78), compared with the control (6.55, 6.81 and 7.21) 
and AGP (6.61, 6.87 and 7.14) group. The use of DFM and Bio-MOS® 
increased length and width of intestinal villa and decreased depth of 
crypts, while the number of goblet cells did not significantly differ among 
experimental groups. In conclusion, Bio-MOS® and DFM exhibited 
nutritional, pharmacological and economic advantages over antibiotic 
growth promoters.
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